MetLife Investment Management’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.11M Buy
86,535
+5,303
+7% +$191K 0.02% 782
2025
Q1
$3.2M Sell
81,232
-3,128
-4% -$123K 0.02% 830
2024
Q4
$2.54M Buy
84,360
+3,752
+5% +$113K 0.01% 922
2024
Q3
$1.89M Hold
80,608
0.01% 1049
2024
Q2
$1.43M Buy
80,608
+8,286
+11% +$147K 0.01% 1145
2024
Q1
$1.1M Hold
72,322
0.01% 1241
2023
Q4
$1.24M Hold
72,322
0.01% 1190
2023
Q3
$605K Hold
72,322
﹤0.01% 1510
2023
Q2
$1.8M Buy
72,322
+2,226
+3% +$55.3K 0.01% 973
2023
Q1
$1.05M Hold
70,096
0.01% 1200
2022
Q4
$829K Hold
70,096
0.01% 1308
2022
Q3
$415K Buy
70,096
+6,093
+10% +$36.1K ﹤0.01% 1768
2022
Q2
$272K Sell
64,003
-7,266
-10% -$30.9K ﹤0.01% 2091
2022
Q1
$678K Buy
71,269
+26,443
+59% +$251K ﹤0.01% 1593
2021
Q4
$852K Hold
44,826
0.01% 1200
2021
Q3
$1.49M Hold
44,826
0.01% 963
2021
Q2
$1.74M Hold
44,826
0.02% 929
2021
Q1
$2.16M Sell
44,826
-2,037
-4% -$98.2K 0.02% 835
2020
Q4
$2.44M Hold
46,863
0.02% 728
2020
Q3
$1.25M Buy
46,863
+3,813
+9% +$102K 0.01% 933
2020
Q2
$839K Buy
43,050
+5,331
+14% +$104K 0.01% 1099
2020
Q1
$371K Hold
37,719
0.01% 1369
2019
Q4
$419K Hold
37,719
﹤0.01% 1554
2019
Q3
$212K Hold
37,719
﹤0.01% 1913
2019
Q2
$326K Buy
37,719
+9,435
+33% +$81.6K ﹤0.01% 1747
2019
Q1
$227K Hold
28,284
﹤0.01% 1913
2018
Q4
$116K Hold
28,284
﹤0.01% 2228
2018
Q3
$158K Hold
28,284
﹤0.01% 2212
2018
Q2
$372K Buy
28,284
+7,358
+35% +$96.8K ﹤0.01% 1594
2018
Q1
$297K Hold
20,926
﹤0.01% 1680
2017
Q4
$172K Buy
+20,926
New +$172K ﹤0.01% 2008